The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

The U.S. government plans to lower Medicare costs for Botox by targeting its medical uses, marking a major shift in drug ...

The selected medications treat a range of conditions, including cancer, psoriatic arthritis, and human immunodeficiency virus ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

CMS has identified 15 prescription drugs to target for lower prices in 2028: Anoro Ellipta, Biktarvy, Botox, Cimzia, Cosentyx, Entyvio, Erleada, Kisqali, Lenvima, Orencia, Rexulti, Trulicity, Verzenio ...

DIY Botox is popular on TikTok, but injecting an internet-sourced neurotoxin into your face is a gamble that can can lead to serious harms.